ArticleACS medicinal chemistry letters2025

Preclinical Characterization of Novel FAP-2286-Based Radioligand with Albumin Binder for Improved Tumor Retention.

Kosuke Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.